OR WAIT null SECS
October 01, 2016
Challenging molecules and markets are driving the development of new solutions for drug delivery.
August 15, 2016
Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.
June 15, 2016
Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.
For successful drug delivery partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
May 18, 2016
The company’s method reduces the time required to crystallize antibodies from weeks to one day.
December 04, 2015
The company plans to reformulate injectable products to make them into inhaled and intranasal medications.
November 20, 2015
Expansions at Catalent’s Kansas City, MO, and Madison, WI facilities made in response to industry demand.
July 07, 2015
Catalent’s licensing of Excelimmune’s antibody combination therapy platform can enable more consistent, cost effective production of antibody combinations.
July 01, 2015
The new facility expands the company’s commercial manufacturing capability at its Bend, Ore. site.
June 15, 2015
Whether outsourcing or developing cell therapies in-house, success demands a focus on quality, cost of goods, and sustainability from the start.